An association study of two functional promotor polymorphisms in the myeloperoxidase (MPO) gene in multiple sclerosis

Multiple Sclerosis

Volumn 13, Issue 6, 2007, Pages 697-700

  Lundmark, Frida ^a   Salter, H ^b   Hillert, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

Author keywords

Association; Genetics; Multiple sclerosis; Myeloperoxidase

Indexed keywords

HYPOCHLOROUS ACID; MYELOPEROXIDASE;

ADULT; ARTICLE; BONE MARROW CELL; CATALYSIS; CAUCASIAN; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME RELEASE; FEMALE; GENE ACTIVITY; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC POLYMORPHISM; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUTROPHIL CHEMOTAXIS; PROMOTER REGION; RISK ASSESSMENT; RISK FACTOR; TISSUE INJURY;

EID: 34447500542     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506075315     Document Type: Article

References (18)

1. Lassmann H. Neuropathology in multiple sclerosis: new concepts. Mult Scler 1998; 4: 93-98.
2. Steinman L, Waisman A, Altmann A. Major T-cell responses in multiple sclerosis. Mol Med Today 1995; 1: 79-83.
3. Ebers GC, Sadovnick AD. The role of genetic factors in multiple sclerosis susceptibility. J Neuroimmunol 1994; 54: 1-17.
4. Dyment DA, Ebers GC, Sadovnick AD. Genetics of multiple sclerosis. Lancet Neurol 2004; 3: 104-10.
5. Dyment DA, Yee IM, Ebers GC, Sadovnick AD; Canadian Collaborative Study Group. Multiple sclerosis in stepsiblings: recurrence risk and ascertainment. J Neurol Neurosurg Psychiatry 2006; 77: 258-59.
6. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC; Canadian Collaborative Study Group. Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci USA 2003; 100: 12877-82.
7. Ebers GC, Sadovnick AD, Dyment DA, Yee IM, Willer CJ, Risch NJ. Parent-of-origin effect in multiple sclerosis: observations in half-siblings. Lancet 2004; 363: 1773-74.
8. Chataway J, Sawcer S, Feakes, Coraddu F, Broadley S, Jones HB et al. A screen of candidates from peaks of linkage: evidence for the involvement of myeloperoxidase in multiple sclerosis. J Neuroimmunol 1999; 98: 208-13.
9. Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ et al. Genomewide scan for multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997; 61: 1379-87.
10. Hoy A, Leininger-Muller B, Kutter D, Siest G, Visvikis S. Growing significance of myeloperoxidase in non-infectious diseases. Clin Chem Lab Med 2002; 40: 2-8.
11. Piedrafita FJ, Molander RB, Vansant G, Orlova EA, Pfahl M, Reynolds WF. An Ale element in the myeloperoxidase promotor contains a composite SP1-thyroid hormone-retinoic acid response element. J Biol Chem 1996; 271: 14412-20.
12. Nagra RM, Becher B, Tourtellotte WW, Antel JP, Gold D, Paladino T et al. Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 1997; 78: 97-107.
13. Kantarci OH, Atkinson EJ, Hebrink DD, McMurray CT, Weinshenker BG. Association of a myeloperoxidase promotor polymorphism with multiple sclerosis. J Neuroimmunol 2000; 105: 189-94.
14. Zakrzewska-Pniewska B, Styczynska M, Podlecka A, Samocka R, Peplonska B, Barcikowska M et al. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis. Mult Scler 2004; 10: 266-71.
15. Nelissen I, Fiten P, Vandenbroeck K, Hillert J, Olssson T, Marrosu MG et al. PECAM 1, MPO and PRKAR1A at chromosome 17q2l-q24 a susceptibility for multiple sclerosis in Sweden and Sardinia. J Neuroimmunol 2000; 108: 153-59.
16. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
17. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-27.
18. Woolf B. On estimating the relation between blood groups and disease. Ann Hum Genet 1955; 19: 251-53.